These emerging medications , Semaglutide , represent a remarkable advancement in addressing obesity and conceivably related conditions . They are grouped as GLP-1 receptor activators , meaning they to emulate the body's GLP-1 peptide, stimulating metabolic release and reducing appetite . Although Semaglutide each one operates somewhat similarly, th